| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
3e-12 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
2e-11 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-09 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
2e-09 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.24 |
1e-06 |
| mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-05 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-05 |